Using serum proteomics, Jennings et al. identify NCAM1 and GDF15 as sensitive and specific biomarkers for axonal and demyelinating forms of CMT in patients and four different mouse models. This evidence concerns the gene GDF15 and Charcot-Marie-Tooth disease.